219 related articles for article (PubMed ID: 32948948)
21. A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia. Molecular genetics report from Saudi Arabia.
Mohamed S; El-Kholy S; Al-Juryyan N; Al-Nemri AM; Abu-Amero KK
Saudi Med J; 2015 Jan; 36(1):113-6. PubMed ID: 25630015
[TBL] [Abstract][Full Text] [Related]
22. A Novel Nonsense Mutation c.374C>G in CYP21A2 Gene of a Vietnamese Patient with Congenital Adrenal Hyperplasia.
Vu CD; Van Ta T; Nguyen NL; Nguyen HH; Nguyen TKL; Tran TH; Tran VK
Adv Exp Med Biol; 2020; 1292():27-35. PubMed ID: 30838541
[TBL] [Abstract][Full Text] [Related]
23. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations.
Wang R; Yu Y; Ye J; Han L; Qiu W; Zhang H; Liang L; Gong Z; Wang L; Gu X
Steroids; 2016 Apr; 108():47-55. PubMed ID: 26804566
[TBL] [Abstract][Full Text] [Related]
24. Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia.
Jang JH; Jin DK; Kim JH; Tan HK; Kim JW; Lee SY; Ki CS; Park HD
Ann Clin Lab Sci; 2011; 41(1):44-7. PubMed ID: 21325254
[TBL] [Abstract][Full Text] [Related]
25. [Genetic analysis and prenatal diagnosis for 25 Chinese pedigrees affected with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Luo C; Jiang T; Zhang J; Li L; Sun Y; Liu G; Wang Y; Cheng J; Ma D; Xu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):832-835. PubMed ID: 30512157
[TBL] [Abstract][Full Text] [Related]
26. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
Xu Z; Chen W; Merke DP; McDonnell NB
J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
[TBL] [Abstract][Full Text] [Related]
28. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
29. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
30. The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes.
Fanis P; Skordis N; Toumba M; Picolos M; Tanteles GA; Neocleous V; Phylactou LA
Front Endocrinol (Lausanne); 2023; 14():1156616. PubMed ID: 37324257
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency.
Ma D; Chen Y; Sun Y; Yang B; Cheng J; Huang M; Zhang J; Zhang J; Hu P; Lin Y; Jiang T; Xu Z
Clin Biochem; 2014 Apr; 47(6):455-63. PubMed ID: 24503005
[TBL] [Abstract][Full Text] [Related]
32. A sequence variation in 3'UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia.
Menabò S; Balsamo A; Baldazzi L; Barbaro M; Nicoletti A; Conti V; Pirazzoli P; Wedell A; Cicognani A
J Endocrinol Invest; 2012 Mar; 35(3):298-305. PubMed ID: 21521936
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of copy number variation of
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511
[No Abstract] [Full Text] [Related]
34. Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Concolino P; Perrucci A; Carrozza C; Urbani A
Mol Diagn Ther; 2023 Sep; 27(5):621-630. PubMed ID: 37548905
[TBL] [Abstract][Full Text] [Related]
35. [Detection of CYP21A2 gene mutations and the differences in the levels of hormones in patients with 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):586-592. PubMed ID: 32164112
[No Abstract] [Full Text] [Related]
36. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
[TBL] [Abstract][Full Text] [Related]
37. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia.
Skordis N; Kyriakou A; Tardy V; Ioannou YS; Varvaresou A; Dracopoulou-Vabouli M; Patsalis PC; Shammas C; Neocleous V; Phylactou LA
Horm Res Paediatr; 2011; 75(3):180-6. PubMed ID: 20838032
[TBL] [Abstract][Full Text] [Related]
38. Rapid detection of common variants and deletions of CYP21A2 using MALDI-TOF MS.
Yin X; Lin Y; Zhang T; Miao H; Hu L; Hu Z; Zhou D; Wu B; Huang X
Eur J Med Genet; 2024 Jun; 69():104950. PubMed ID: 38830573
[TBL] [Abstract][Full Text] [Related]
39. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency.
Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB
Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666
[TBL] [Abstract][Full Text] [Related]
40. Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.
Prado MJ; de Castro SM; Kopacek C; de Mello MP; Rispoli T; Grandi T; da Silva CMD; Rossetti MLR
Mol Diagn Ther; 2017 Dec; 21(6):663-675. PubMed ID: 28819757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
